Our Surgical Oncology Department is the clinical core for the operative management of solid organ cancers, acting as a vital partner within our hospital's multidisciplinary cancer program. Our mission, guided by the highest standards from globally benchmarked institutions, is three-fold:
We use advanced surgical techniques, such as biopsy and sentinel lymph node mapping, to accurately determine the type and extent (stage) of the cancer, which is critical for planning the most effective treatment course.
Our primary goal is to achieve complete tumor clearance—the removal of the entire tumor with microscopically negative margins (R0 resection)—to maximize the chances of long-term local control and survival.
We are committed not just to removing cancer, but also to preserving function and maximizing quality of life, using techniques that minimize surgical impact and expedite recovery.
We treat cancer as a complex, multifaceted disease, ensuring surgical intervention is expertly sequenced with medical and radiation oncology, providing care that is both comprehensive and personalized.
Our team of specialized surgical oncologists provides expert consultation, diagnosis, and treatment for a wide range of complex and common cancers, utilizing the latest evidence-backed techniques to achieve optimal outcomes.
This includes Laparoscopic and Robotic-Assisted Surgery, allowing for complex resections through small incisions, leading to faster healing and less scarring.
A highly specialized two-step procedure involving the surgical removal of visible tumors (Cytoreductive Surgery) followed by a heated chemotherapy solution circulated directly within the abdominal cavity for peritoneal cancers.
Working closely with Plastic Surgery, we ensure immediate reconstruction following large tumor resections (e.g., breast, head and neck, soft tissue).
Precise diagnostic procedures, including image-guided and core needle biopsies.
Choosing our department means choosing a team dedicated to global standards of cancer care and innovation.
Our surgeons are highly fellowship-trained and specialize in specific organ systems (e.g., HPB, Melanoma), ensuring you benefit from unparalleled knowledge and technical skill, mirroring the model of leading global cancer centers like MD Anderson and Mayo Clinic.
Every patient's case is reviewed in a Tumor Board meeting involving Surgical, Medical, and Radiation Oncologists, guaranteeing that your treatment plan is comprehensive, personalized, and follows the latest ASCO/NCCN guidelines.
We utilize the latest robotic systems (e.g., Da Vinci) for complex procedures, which provides surgeons with 3D visualization and superior dexterity, leading to more accurate dissection, reduced blood loss, and excellent functional outcomes.
The use of Intraoperative Ultrasound and other advanced imaging tools during surgery allows the surgeon to visualize tumors and margins in real-time, enhancing the safety and completeness of the resection.
We implement evidence-based protocols to manage pain, nutrition, and mobility immediately after surgery, helping to shorten your hospital stay and dramatically speed up your return to normal life.
By prioritizing minimally invasive techniques where appropriate, we reduce the physical toll of surgery, which is particularly beneficial when further treatments like chemotherapy or radiation are planned.
MBBS, MS-Gen Surg (1976), FRCS (Edin)(1981), FRCS(Glas)(1981)
HOD, Senior Consultant Surgical OncologistSurgical Oncology
MBBS, MS - Gen Surgery (March 1972), DABS (1977), M.Ch, FICS (1985)
Senior Consultant Surgical OncologistSurgical Oncology
MBBS, DNB Gen Surg (1993), Fellow Adv Lap & Robotic Surg (2005)
Senior Consultant Surgical OncologistSurgical Oncology
MBBS, MS-Gen Surgery (Oct 2005), MCh-Surgical Oncology (July 2014)
Senior ConsultantSurgical Oncology
MBBS, MS-Gen Surgery (May 2012), MCh-Surgical Oncology (July 2017)
Senior ConsultantSurgical Oncology
MBBS, MS-Gen Surgery (June 2013), MCh-Surgical Oncology (July 2016)
Senior ConsultantSurgical Oncology
MBBS, MS-Gen Surgery (2012), DNB-Gen Surgery (2012), MRCS (2014), DNB - Surgical Oncology (2017), MCh-Surgical Oncology (2017)
ConsultantSurgical Oncology
MBBS, MS - Gen Surgery (June 2015), DNB - Gen Surgery, MCh - Endocrine Surgery (Nov 2020), Fellowship in Minimal Access Surgery
ConsultantSurgical Oncology
MBBS, MS-Gen Surgery (2017), Fellowship in Breast Cancer Diseases (July 2019), MCh Breast Oncoplasty (Dec 2022)
ConsultantSurgical Oncology
MBBS, MS-Gen Surgery (Jun 2018), MCh-Surgical Oncology (Jan 2024)
Junior ConsultantSurgical Oncology
MBBS, MS-Gen Surgery (May 2002), MCh-Surgical Oncology (July 2005)
Visiting ConsultantSurgical Oncology
MBBS, MS - General Surgery (2010), MCh-Cardio Thoracic and Vascular Surgery (Aug 2014), Surgical Oncology - Thoracic Fellowship (2019), MTI Fellowship Thoracic Surgery (Mar 2020), Minimally Invasive Thoracic Surgery (June 2024)
Visiting ConsultantSurgical Oncology
MBBS, MS-Gen Surgery (1997), ASTS Abdominal Organ transplant fellowship (2009), Masters in Experimental Surgery (2011)
ConsultantSurgical Oncology